Cuc D administration showed a significant reduction (p < 0.05) in the expression of PCNA and MUC13 protein levels in excised xenograft tumor tissues, further indicating that Cuc D has the potential to inhibit xenograft-derived human pancreatic cancer cells. The gene discussed is PCNA; the disease is familial pancreatic carcinoma.